Get started
Author

Lars Johansson

Observed names: Johansson, Lars, Johansson, Lars Å., L Johansson, L. Johansson, L.A. Johansson, Lars A. Johansson, Lars Å. Johansson
Institution: Umeå University
ORCID: 0000-0002-9303-3228
Observed ORCID: 0000-0002-9303-3228
OpenAlex ID: A5101990652
Safety of the oral factor XIa inhibitor asundexian compared with apixaban in patients with atrial fibrillation (PACIFIC-AF): a multicentre, randomised, double-blind, double-dummy, dose-finding phase 2 study
2022 · Jonathan P Piccini, Valeria Caso, et al. · The Lancet · 350
PDF
Estimating the prevalence of atrial fibrillation in a general population using validated electronic health data
2013 · Lars Johansson, Johannes Norberg, et al. · Clinical Epidemiology · 86
PDF
Age-specific atrial fibrillation incidence, attributable risk factors and risk of stroke and mortality: results from the MORGAM Consortium
2021 · Bente Morseth, Bastiaan Geelhoed, et al. · Open Heart · 80
PDF
Positive predictive value and misclassification of diagnosis of pulmonary embolism and deep vein thrombosis in Swedish patient registries
2018 · Ludvig Öhman, Magdalena Johansson, et al. · Clinical Epidemiology · 61
PDF
Bleeding complications during warfarin treatment in primary healthcare centres compared with anticoagulation clinics
2007 · Jonas Wallvik, Anders Själander, et al. · Scandinavian Journal of Primary Health Care · 60
PDF
Thrombomodulin as a Marker for Bleeding Complications During Warfarin Treatment
2009 · Marcus Lind, Kurt Boman, et al. · Archives of Internal Medicine · 36
Incidence, type of atrial fibrillation and risk factors for stroke: a population-based cohort study
2017 · Cecilia Johansson, Erik Dahlqvist, et al. · Clinical Epidemiology · 29
PDF
Incidence and risk factors of venous thromboembolism in men and women
2022 · Marcus M. Lind, Magdalena Johansson, et al. · Thrombosis Research · 28
PDF
D-Dimer Is Associated With First-Ever Intracerebral Hemorrhage: A Nested Case-Control Study
2018 · Kristina Johansson, Jan-Håkan Jansson, et al. · Stroke · 28
Characterization of patients with atrial fibrillation not treated with oral anticoagulants
2014 · Cecilia Johansson, Lovisa Hägg, et al. · Scandinavian Journal of Primary Health Care · 28
PDF
Alcohol consumption and risk of incident atrial fibrillation: A population-based cohort study
2020 · Cecilia Johansson, Marcus M Lind, et al. · European Journal of Internal Medicine · 26
Signs of dysregulated fibrinolysis precede the development of type 2 diabetes mellitus in a population-based study
2012 · Jenny Hernestål-Boman, Margareta Norberg, et al. · Cardiovascular Diabetology · 25
PDF
Physical activity and risk of first-time venous thromboembolism
2019 · Magdalena Johansson, Lars Johansson, et al. · European Journal of Preventive Cardiology · 24
Diabetes, prediabetes, and atrial fibrillation—A population‐based cohort study based on national and regional registers
2023 · Cecilia Johansson, Lina Örtendahl, et al. · Journal of Internal Medicine · 23
PDF
Association between inflammasome-related polymorphisms and psoriatic arthritis
2020 · K Juneblad, A Kastbom, et al. · Scandinavian Journal of Rheumatology · 22
PDF
External Validity of the ARISTOTLE Trial in Real‐Life Atrial Fibrillation Patients
2014 · Lovisa Hägg, Cecilia Johansson, et al. · Cardiovascular Therapeutics · 21
PDF
Fasting plasma glucose, oral glucose tolerance test, and the risk of first-time venous thromboembolism. A report from the VEINS cohort study.
2018 · Magdalena Johansson, Marcus Lind, et al. · Thrombosis Research · 20
Factor XII as a Risk Marker for Hemorrhagic Stroke: A Prospective Cohort Study
2017 · Kristina Johansson, Jan-Håkan Jansson, et al. · Cerebrovascular Diseases Extra · 18
PDF
Von Willebrand factor predicts major bleeding and mortality during oral anticoagulant treatment
2011 · M. Lind, K. Boman, et al. · Journal of Internal Medicine · 17
d-dimer predicts major bleeding, cardiovascular events and all-cause mortality during warfarin treatment
2014 · Marcus Lind, Kurt Boman, et al. · Clinical Biochemistry · 13
Weight, height, weight change, and risk of incident atrial fibrillation in middle‐aged men and women
2020 · Cecilia Johansson, Marcus M. Lind, et al. · Journal of Arrhythmia · 11
PDF
Warfarin persistence among atrial fibrillation patients – why is treatment ended?
2016 · Fredrik Björck, Agnes Ek, et al. · Cardiovascular Therapeutics · 9
Telemedicine improves the monitoring process in anticoagulant treatment
2012 · Kurt Boman, Thomas Davidson, et al. · Journal of Telemedicine and Telecare · 8
Von Willebrand factor, ABO blood group, and risk of first-ever intracerebral hemorrhage: A prospective nested case-control study
2020 · Kristina Johansson, Jan-Håkan Jansson, et al. · Thrombosis Research · 7
High homocysteine and low folate plasma concentrations are associated with cardiovascular events but not bleeding during warfarin treatment
2016 · Marcus Lind, Jan-Håkan Jansson, et al. · Clinical Chemistry and Laboratory Medicine (CCLM) · 7
Works count: 43
Citation count: 1,067
H-index: 18
I10-index: 21
Year
Topic
Type